Report Scope:
The report explains critical trends in the influenza vaccine industry. It discusses the market determinants, which act as motivating or restraining factors, and provides insights to stakeholders and potential entrants.
This report study includes only human vaccines; animal vaccines have not been considered in this report.
This study looks at most of the systems affected by factors such as considerable research and development spending and increasing competition and new technologies, which are giving direction to the market. These advancements, new product launches and changing lifestyles are influencing future market growth.
Company merger acquisition strategies and collaborations are also covered in this report. Additionally, this study discusses the strengths and weaknesses of each strategy type considering new technologies, growing competition and changing customer needs.
The market has also been analyzed based on the type of influenza vaccines. Categories considered in this report include inactivated vaccines and live-attenuated vaccines.
This study details market growth among vaccine manufacturers and end users. Genomic research centers, academic institutions, government and private laboratories and various hospital settings, as well as pharmaceutical, diagnostic and biotechnology companies and physicians, will find this study to be of interest.
The report provides useful information to all market players, potential entrants, government agencies and other interested parties. As the report covers geographic regions in detail, companies interested in expanding their geographic reach will also find this study useful.
Report Includes:
- 20 data tables and 29 additional tables
- An updated overview of the global market for influenza vaccines within the biopharmaceutical industry
- Analyses of the global market trends, with historic revenue (sales) data for 2019-2021, and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation and forecast the market size for influenza vaccines, and corresponding market share analysis by type, technology, age, and region
- Information on baloxavir marboxil (Xofluza) vaccine, along with types of influenza virus strains used for vaccine preparation like influenza type A with H3N2 virus strain, influenza type A with H1N1 virus strain, and influenza type B virus strain
- Country specific data and market value analysis for the U.S., Canada, Germany, U.K., France, Italy, Spain, Australia, Japan, China and India
- Technology assessment of the key drivers, restraints and opportunities that will shape the market over the next five years (2021 to 2026)
- Discussion of technology advancements in influenza vaccines development, product innovations, government regulations, clinical trials, and other key market strategies
- Coverage of key merger acquisition strategies and collaboration agreements in the marketplace
- In-depth information on increasing investments on R&D activities, key technology issues, industry specific challenges, major types of end-user markets, and COVID-19 implications on the progress of this market
Descriptive company profiles of the leading global players, including AstraZeneca, CSL Ltd., Abbott Laboratories, GlaxoSmithKline plc and Sanofi
Summary:
The global influenza vaccines market was valued at REDACTED in 2020. By type, this market has been segmented into inactivated and live-attenuated vaccines. The inactivated influenza vaccine (IIV) segment recorded REDACTED revenue in 2020 and is estimated to grow at a compound annual growth rate (CAGR) of REDACTED during the forecast period. The fast growth rate of the inactivated vaccines is attributed to increasing company investments in IIV development and the excellent stability profile of this vaccine type, which has a proven record of safety and immune response.
The global influenza vaccines market is segmented in this report by type, technology, age and region.
Reasons for Doing This Study:
The World Health Organization estimates that seasonal influenza may result in 290,000 to 650,000 deaths annually due to respiratory diseases alone. There are several reasons to get the influenza (flu) vaccine each year. Flu vaccination is the best way to obtain protection against flu and possibly severe complications. Flu vaccinations avoid millions of instances of illness and flu-related doctor's visits each year. For instance, during 2019-2020, flu vaccination averted a projected 7.5 million instances of influenza illnesses, 3.7 million influenza-related medical visits, 105,000 influenza-associated hospitalizations and 6,300 influenza-associated fatalities. Vaccination is one of the most cost-effective
ways to reduce the seasonal influenza disease load. The overall increase in infectious and noninfectious diseases, growing population, technological advancements and continuous innovations are creating a considerable scope for the influenza vaccines market. The resurgence of vaccine-preventable diseases and the emergence of new pandemics and immunization programs in emerging economies also influence the global influenza vaccines market. This report is designed to be a critical decision-making tool for the intended audience, including influenza vaccine manufacturing players, potential market entrants and other professionals involved with or interested in immunology and vaccine-preventable seasonal influenza.
Influenza Vaccines: Global Markets
Table of Contents
Chapter 1 Introduction
Study Background
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Definitions
Immune System and Vaccines
How Vaccines Work?
Influenza Vaccines - Overview
The Pathogen
Signs and Symptoms
Epidemiology
Diagnosis
Prevention
Type of Influenza Vaccines
Annual Selection of Viruses
Production
Inactivated Influenza Vaccines (IIVs)
Live-attenuated Influenza Vaccines (LAIVs)
Regulatory Aspects
Chapter 4 Impact of Covid-19
Overview
Impact of Covid-19 on the 2021-2022 Flu Season
Low Levels of Flu May Lead to Contentment About Getting the Vaccine
Positive Impact of Covid-19 on Flu Vaccination Rates
Influenza Vaccination Increased During the Covid-19 Pandemic
Chapter 5 Influenza Vaccines Market Dynamics
Market Drivers
Increase in Government Support and Surveillance Regarding Vaccination Against Influenza at the National and Global Levels
Growing Awareness of Immunization Across the Globe
The Rise in Investment by Top Market Players Across the Globe and Growth in Government Funding Has Facilitated the Launch of Therapeutically Effective Vaccines
Market Restraints
Stringent Regulatory Requirements Along with Prolonged Duration of Clinical Trials
Limited Adoption of Influenza Vaccines in Low- and Middle-Income Countries (LMICs)
Market Opportunities
Demand for Universal Flu Vaccines Fuels the Need to Develop Innovative Approaches for Vaccine Development
Competitive Landscape
Company Share Analysis
Chapter 6 Market Breakdown by Type
Global Influenza Vaccines Market, by Type
Inactivated Vaccines
Market Size and Forecast
Live-attenuated Vaccines
Market Size and Forecast
Chapter 7 Market Breakdown by Technology
Global Influenza Vaccines Market, by Technology
Egg-based
Market Size and Forecast
Cell-based Vaccine
Market Size and Forecast
Chapter 8 Market Breakdown by Age
Global Influenza Vaccines Market, by Age
Pediatric
Market Size and Forecast
Adults
Among Adults, Who Should Not Get the Flu Vaccine?
Market Size and Forecast
Chapter 9 Market Breakdown by Region
Global Influenza Vaccines Market, by Region
North America
U.S.
Canada
Europe
National Recommendations Across Europe
Achieved Coverage
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
Australia
India
Rest of Asia-Pacific
Rest of the World
Market Size and Forecast
Chapter 10 Company Profiles
ABBOTT LABORATORIES
ASTRAZENECA PLC
BIODIEM LTD.
BHARAT BIOTECH INTERNATIONAL LTD.
CSL LTD.
EMERGENT BIOSOLUTIONS INC.
GLAXOSMITHKLINE PLC
GC BIOPHARMA (GREEN CROSS CORP.)
NOVAVAX INC.
SANOFI
SINOVAC BIOTECH LTD.
Chapter 11 Appendix: List of Abbreviations
List of Tables
Summary Table : Global Influenza Vaccines Market, by Type, Through 2026
Table 1 : Seasonal Influenza Vaccines
Table 2 : U.S. Influenza Vaccines for the 2021-2022 Influenza Season
Table 3 : Global Influenza Vaccines Market, by Type, Through 2026
Table 4 : Global Inactivated Influenza Vaccines Market, by Region, Through 2026
Table 5 : Global Live-attenuated Influenza Vaccines Market, by Region, Through 2026
Table 6 : Global Influenza Vaccines Market, by Technology, Through 2026
Table 7 : Egg-based Influenza Vaccine Products for 2021-2022 Influenza Season
Table 8 : Global Egg-based Influenza Vaccines Market, by Region, Through 2026
Table 9 : Global Cell-based Influenza Vaccines Market, by Region, Through 2026
Table 10 : Global Influenza Vaccines Market, by Age, Through 2026
Table 11 : Influenza Vaccines by Age
Table 12 : Influenza Vaccine Price List, 2020
Table 13 : Global Market for Pediatrics in Influenza Vaccines, by Region, Through 2026
Table 14 : Global Market for Adults in Influenza Vaccines, by Region, Through 2026
Table 15 : Global Influenza Vaccines Market, by Region, Through 2026
Table 16 : North American Influenza Vaccines Market, by Type, Through 2026
Table 17 : North American Influenza Vaccines Market, by Country, Through 2026
Table 18 : U.S. Cumulative 2021/2022 Season Lot Release Status (Updated 11/3/2021)
Table 19 : Overview of Available Seasonal Influenza Vaccines in the E.U./E.E.A.
Table 20 : European Influenza Vaccines Market, by Type, Through 2026
Table 21 : European Influenza Vaccines Market, by Country, Through 2026
Table 22 : Influenza Vaccines Marketed in the U.K. for the 2022-2023 Influenza Season
Table 23 : Asia-Pacific Influenza Vaccines Market, by Type, Through 2026
Table 24 : Asia-Pacific Influenza Vaccines Market, by Country, Through 2026
Table 25 : Rest of the World Influenza Vaccines Market, by Type, Through 2026
Table 26 : Abbott Laboratories: Vaccines Offered
Table 27 : AstraZeneca: Vaccines Offered
Table 28 : AstraZeneca: Recent Developments
Table 29 : BioDiem Ltd.: Vaccines Offered
Table 30 : BioDiem Ltd.: Recent Developments
Table 31 : Bharat Biotech: Vaccines Offered
Table 32 : Bharat Biotech: Recent Developments
Table 33 : CSL Ltd. (Seqirus): Vaccines Offered
Table 34 : CSL Ltd. (Seqirus): Recent Developments
Table 35 : Emergent BioSolutions Inc.: Vaccines Offered
Table 36 : Emergent BioSolutions Inc.: Recent Developments
Table 37 : GlaxoSmithKline plc: Vaccines Offered
Table 38 : GlaxoSmithKline plc: Flu Vaccines Sales, 2019-2020
Table 39 : GlaxoSmithKline plc: Recent Developments
Table 40 : GC Biopharma: Vaccines Offered
Table 41 : GC Biopharma: Recent Developments
Table 42 : Novavax Inc.: Vaccines Offered
Table 43 : Novavax Inc.: Recent Developments
Table 44 : Sanofi: Vaccines Offered
Table 45 : Sanofi: Recent Developments
Table 46 : Sinovac Biotech Ltd.: Vaccines Offered
Table 47 : Sinovac Biotech Ltd.: Recent Developments
Table 48 : Abbreviations Used in the Vaccine Technologies Market
List of Figures
Summary Figure : Global Influenza Vaccines Market Share, by Type, 2020
Figure 1 : Timeline of Influenza Vaccine History
Figure 2 : Global Influenza Vaccines Market Share, by Companies, 2020
Figure 3 : Global Influenza Vaccines Market Share, by Type, 2020
Figure 4 : Global Inactivated Influenza Vaccines Market, 2019-2026
Figure 5 : Global Inactivated Influenza Vaccines Market, by Region, 2019-2026
Figure 6 : Global Live-attenuated Influenza Vaccines Market, 2019-2026
Figure 7 : Global Live-attenuated Influenza Vaccines Market, by Region, 2019-2026
Figure 8 : Global Market Share for Influenza Vaccines, by Technology, 2020
Figure 9 : Global Egg-based Influenza Vaccines Market, 2019-2026
Figure 10 : Global Egg-based Influenza Vaccines Market, by Region, 2019-2026
Figure 11 : Evolution of Influenza Vaccine Substrates from Embryonated Eggs to Cells
Figure 12 : Global Cell-based Influenza Vaccines Market, 2019-2026
Figure 13 : Global Cell-based Influenza Vaccines Market, by Region, 2019-2026
Figure 14 : Global Market Share for Influenza Vaccines, by Age, 2020
Figure 15 : Global Market for Pediatrics in Influenza Vaccines, 2019-2026
Figure 16 : Global Market for Pediatrics in Influenza Vaccines, by Region, 2019-2026
Figure 17 : Global Market for Adults in Influenza Vaccines, 2019-2026
Figure 18 : Global Market for Adults in Influenza Vaccines, by Region, 2019-2026
Figure 19 : Global Influenza Vaccines Market, by Region, 2019-2026
Figure 20 : Global Influenza Vaccines Market Share, by Region, 2020
Figure 21 : North American Influenza Vaccines Market Share, by Technology, 2020
Figure 22 : North American Influenza Vaccines Market Share, by Country, 2020
Figure 23 : U.S. Influenza Vaccines Market, 2019-2026
Figure 24 : Canadian Seasonal Flu Vaccination Coverage, 2018-2019 to 2020-2021 Flu Seasons
Figure 25 : Canadian Influenza Vaccines Market, 2019-2026
Figure 26 : European Influenza Vaccines Market Share, by Type, 2020
Figure 27 : European Influenza Vaccines Market Share, by Country, 2020
Figure 28 : German Influenza Vaccines Market, 2019-2026
Figure 29 : French Influenza Vaccines Market, 2019-2026
Figure 30 : U.K. Influenza Vaccines Market, 2019-2026
Figure 31 : Italian Influenza Vaccines Market, 2019-2026
Figure 32 : Spanish Influenza Vaccines Market, 2019-2026
Figure 33 : Rest of the European Influenza Vaccines Market, 2019-2026
Figure 34 : Asia-Pacific Influenza Vaccines Market Share, by Type, 2020
Figure 35 : Asia-Pacific Influenza Vaccines Market Share, by Country, 2020
Figure 36 : Chinese Influenza Vaccines Market, 2019-2026
Figure 37 : Japanese Influenza Vaccines Market, 2019-2026
Figure 38 : Australian Influenza Vaccines Market, 2019-2026
Figure 39 : Indian Influenza Vaccines Market, 2019-2026
Figure 40 : Rest of Asia-Pacific Influenza Vaccines Market, 2019-2026
Figure 41 : Rest of the World Influenza Vaccines Market Share, by Type, 2020
Figure 42 : Abbott Laboratories: Net Revenue, 2016-2020
Figure 43 : Abbott Laboratories: Revenue Share, by Business Segment, 2020
Figure 44 : Abbott Laboratories: Revenue Share, by Country, 2020
Figure 45 : AstraZeneca: Net Revenue, 2017-2021
Figure 46 : AstraZeneca: Revenue Share, by Business Segment, 2021
Figure 47 : AstraZeneca: Revenue Share, by Region, 2021
Figure 48 : CSL Ltd. (Seqirus): Net Revenue, 2017-2021
Figure 49 : CSL Ltd. (Seqirus): Revenue Share, by Business Segment, 2021
Figure 50 : Emergent BioSolutions Inc.: Net Revenue, 2016-2020
Figure 51 : GlaxoSmithKline plc: Net Revenue, 2016-2020
Figure 52 : GlaxoSmithKline plc: Revenue Share, by Business Segment, 2020
Figure 53 : GlaxoSmithKline plc: Revenue Share, by Region, 2020
Figure 54 : Novavax Inc.: Net Revenue, 2016-2020
Figure 55 : Novavax Inc.: Revenue Share, by Business Segment, 2020
Figure 56 : Novavax Inc.: Revenue Share, by Region, 2020
Figure 57 : Sanofi: Net Revenue, 2017-2021
Figure 58 : Sanofi: Revenue Share, by Business Segment, 2021
Figure 59 : Sanofi: Revenue Share, by Region, 2021
Global Encephalitis Vaccination Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 102
According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period.
The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......
Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 123
Market Overview of Global Avian Influenza Vaccines market:
According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years.
Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 96
According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period.
The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......
Global Avian Influenza Vaccines Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 155
According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period.
The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......
Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 28-Dec-2023 Price: US 3380 Onwards Pages: 106
Market Overview of Global Encephalitis Vaccination market:
According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......
Global Influenza Vaccine Market Research Report 2023
Published: 28-Dec-2023 Price: US 2900 Onwards Pages: 96
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Sanofi
- CSL
- GSK
- Viatris
- AstraZeneca
- Hualan Bio
- Changchun Institute of Biological
- Sinovac
- BCHT
- Jiangsu G......
Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 26-Dec-2023 Price: US 3380 Onwards Pages: 117
Market Overview of Global Japanese Encephalitis Vaccine market:
According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 14-Dec-2023 Price: US 3380 Onwards Pages: 103
Market Overview of Global Influenza Vaccine market:
According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses...
......
2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel
Published: 11-Dec-2023 Price: US 2500 Onwards Pages: 107
This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Influenza Vaccine from......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
